Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Safety notes: Multi-year trials cited by the Alzheimer's Drug Discovery Foundation (2015) found no severe adverse events in older adults, and a 2002 trial of 162 patients reported no serious side effects in the treatment group
It upregulates the expression of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and their respective receptors at sites of injury, directly promoting angiogenesis and epithelial repair
(2018) 16:e2002864
Research Background & Mechanistic Focus Current research use centers on copper-associated peptide signaling and structural-response pathway models, comparative presentation or formulation behavior where applicable, and controlled experimental models designed to evaluate compound-specific signaling activity within non-clinical laboratory systems
M., Jantos, H., & Monti, D
US$ 21.34
US$ 26.83
US$ 20.74
